Dong-A ST starts commercializing 2- and 3-drug DPP-4 inhibitor diabetes treatments – KBR
Dong-A ST steps up commercializing two- or three-drug therapy by combining DPP-4 inhibitor diabetes treatment Suganon and SLGT-2 inhibitors.According to KIPRIS, a patent-related information search service, on Tuesday, Dong-A ST…